Disseminated Cryptococcus neoformans infection associated to COVID-19

Sajjad, 2021, Origin, pathogenesis, diagnosis and treatment options for SARS-CoV-2: a review, Biologia (Bratisl), 1 Bhatt, 2021, High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections, Discoveries, 9, e126, 10.15190/d.2021.5 Chon, 2021, Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review, J. Hosp. Infect., 113, 115, 10.1016/j.jhin.2021.04.012 Hoenigl, Martin and Seidel, Danila and Carvalho, Agostinho and Rudramurthy, Shivaprakash M. and Arastehfar, Amir and Gangneux, Jean Pierre and Nasir, Nosheen and Bonifaz, Alexandro and Araiza, Javier and Klimko, Nikolai and Serris, Alexandra and Lagrou, Katrien and Meis, Jacques F. and Cornely, Oliver A. and Perfect, John R. and White, P. Lewis and Chakrabarti, Arunaloke and Group, ECMM and ISHAM Collaborators, The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases from 18 Countries (May 12, 2021).SSRN. Salehi, 2020, Opportunistic fungal infections in the epidemic area of COVID-19: a clinical and diagnostic perspective from Iran, Mycopathologia, 1 Khatib, 2020, Cryptococcemia in a patient with COVID-19: a case report, Clin Case Rep, 9, 853, 10.1002/ccr3.3668 Passarelli, 2020, Detected SARS-CoV-2 in ascitic fluid followed by cryptococcemia: a case report, SN Compr Clin Med, 1 Anekthananon 1, 2011, Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients, Int. J. STD AIDS, 22, 665, 10.1258/ijsa.2011.010538 Qu, 2020, The utility of cerebrospinal fluid white cell count during the prognostic assessment for cryptococcal meningitis patients: a retrospective study, BMC Infect. Dis., 20, 571, 10.1186/s12879-020-05287-x Jean, 2002, Cryptococcaemia: clinical features and prognostic factors, QJM, 95, 511, 10.1093/qjmed/95.8.511